EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase II)Open Access · CC BY-NC-ND 4.0

Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19

Amy L Lightner, Vikram Sengupta, Sascha Qian, John T Ransom, Sam Suzuki, David J Park, Timothy I Melson, Brian P Williams, James J Walsh, Mustafa Awili

CHEST · 2023-12 · 164 (6) · 1444-1453

DOI: 10.1016/j.chest.2023.06.024 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift CHEST, 2023-12. Verfasst von Amy L Lightner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Direct Biologics, LLC, Austin, TX. Electronic address: ALightner@directbiologics.com. Hauptthemen laut MEDLINE: COVID-19, Respiratory Insufficiency, Respiratory Distress Syndrome, Extracellular Vesicles. Die Arbeit wurde bisher 162-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory InsufficiencyRespiratory Distress SyndromeExtracellular VesiclesMesenchymal Stem CellsHumansProspective StudiesTreatment OutcomeDouble-Blind Method

Stichwörter der Autor:innen

COVID-19bone marrow mesenchymal stem cellefficacyextracellular vesiclesafety

Autor:innen und Institutionen

  • Direct Biologics, LLC, Austin, TX. Electronic address: ALightner@directbiologics.com.
  • Direct Biologics, LLC, Austin, TX.
  • Providence St Jude Medical Center/Providence Medical Foundation, Fullerton, CA.
  • Helen Keller Hospital, Sheffield, AL.
  • Covenant Health, Lubbock, TX.
  • Donald Guthrie Foundation, Sayre, PA.

Zitieren

APA

Lightner, A. L., Sengupta, V., Qian, S., Ransom, J. T., Suzuki, S., Park, D. J., Melson, T. I., Williams, B. P., Walsh, J. J., & Awili, M. (2023). Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19. CHEST, 164(6), 1444-1453. https://doi.org/10.1016/j.chest.2023.06.024

Vancouver

Lightner AL, Sengupta V, Qian S, Ransom JT, Suzuki S, Park DJ, et al. Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19. CHEST. 2023;164(6):1444-1453. doi:10.1016/j.chest.2023.06.024

BibTeX
@article{Lightner2023,
  author = {Lightner, Amy L and Sengupta, Vikram and Qian, Sascha and Ransom, John T and Suzuki, Sam and Park, David J and Melson, Timothy I and Williams, Brian P and Walsh, James J and Awili, Mustafa},
  title = {Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19},
  journal = {CHEST},
  year = {2023},
  volume = {164},
  number = {6},
  pages = {1444--1453},
  doi = {10.1016/j.chest.2023.06.024}
}
Kostenlos starten →